about
HIV infection of human brain capillary endothelial cells--implications for AIDS dementia.The hypothalamic-pituitary-adrenocortical system and sleep in man.Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking.Evidence for a sleep-promoting influence of stress.Influence of host defense activation on sleep in humans.Cytokines in sleep regulation.Sleep regulation: interactions among cytokines and classical neurotransmitters.Interactions between cytokines and nitric oxide.Prostaglandins and sleep.Towards a molecular biology of the circadian clock and sleep of mammals.Sleep deprivation and human immune function.The use of morphine in surgery: an overview.gp120 neurotoxicity in primary cortical cultures.The role of the blood-brain barrier in HIV infection of the central nervous system.The role of the thymus in myasthenia gravis.The role of major histocompatibility complex genes in myasthenia gravis and experimental autoimmune myasthenia gravis pathogenesis.Molecular recognition of acetylcholine receptor. Recognition by alpha-neurotoxins and by immune and autoimmune responses and manipulation of the responses.T cell receptor gene regulation of experimental autoimmune myasthenia gravis.Nicotinic acetylcholine receptor: structure, function and main immunogenic region.Aetiological factors in development of myasthenia gravis.Idiotypes in myasthenia gravis.Molecular and structural characterization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.Examination of characteristics that may distinguish disease-causing from benign AChR-reactive antibodies in experimental autoimmune myasthenia gravis.Fatal familial insomnia: sleep, neuroendocrine and vegetative alterations.Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome.Lentiviral infection, immune response peptides and sleep.Sleep, sleep deprivation and infectious disease: studies in animals.gp120 as an etiologic agent for NeuroAIDS: neurotoxicity and model systems.gp120-mediated alterations in astrocyte ion transport.Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide.An experimental model system for HIV-1-induced brain injury.Cytokine dysregulation in HIV-associated neurological disease.Clinical comparison of adult and pediatric NeuroAIDS.Human neural xenografts: progress in developing an in-vivo model to study human immunodeficiency virus (HIV) and human cytomegalovirus (HCMV) infection.Neuronal substrates for SIV encephalopathy.Immune regulatory and effector properties of human adult microglia studies in vitro and in situ.In vivo and in vitro infection of the astrocyte by HIV-1.Activation of HIV-1 transcription by Tat in cells derived from the CNS: evidence for the participation of NF-kappa B--a review.Neuroglial-specific factors and the regulation of retrovirus transcription.The stress response and autoimmunoregulation.
P1433
Q39273194-22E999A3-2B53-4181-8EF9-0A603CC7C717Q40381250-3DE04B6B-607E-4BA6-B7DE-434E5BE45EC9Q40381256-4DC0C3DD-2006-434A-9AD0-3EE029A1A225Q40381261-2F9FF3DE-7125-435B-9D6F-0D0F7DC58E5FQ40381265-FCFED43D-587B-47BC-949B-1664F22247ADQ40381272-1296EFC4-2F76-4572-9082-99D56F52BF32Q40381279-A949F801-1156-4A6A-BF5D-4F4879FB4969Q40381284-F6432CC1-CABC-45E7-9593-3C650FF3E816Q40381290-F4E96E3A-42DD-47C9-9BCF-E4203991DFC5Q40381295-49542A8D-CA50-4D41-9BC2-0D54A0B06973Q40381302-6D68F853-DA19-45A4-ADB0-48B282A23E54Q40394088-E26C7C39-BC2B-423D-8FBC-AF74E74B45ADQ40398144-F87B17AD-A10F-4DC9-97B5-7DB587B396DBQ40398154-E0FA04A0-5C90-4639-9788-C8933BA10CE7Q40399773-42F19A35-2D44-4DB2-AE13-827C6368110BQ40399777-925E1D84-602C-4F58-9FC3-864D1A867203Q40399783-5CBCC971-4684-41F1-A557-B27938A7C826Q40399790-AF6E20D1-2999-4014-B3F9-973D5DFD99DAQ40508071-0D366788-ABC2-48FB-964A-773FD6414580Q40508073-C986E0CC-2232-43F0-BD15-8364EB51137AQ40508079-3F172D42-5D00-44F5-9FAF-A467FAF4A4B9Q40508085-728720BE-3190-4809-BACD-CA1AB0630EECQ40508092-5A86B379-2234-46A2-B3D0-3921AB412653Q40553060-4C3B6B2D-0C2A-4BE1-9C71-98C24F025FC9Q40553069-1A962581-3999-4F16-A355-5256D09C9161Q40553075-2854EFA9-7C6F-4015-90B6-F14951743F35Q40553080-866E85D6-4371-4962-BAF3-ADD2D7926209Q40603246-0EAAF46C-DF72-457F-81EC-4000666DBF64Q40603251-035EFA8B-DB0D-4359-B864-9F357748FA74Q40603257-11246221-15E2-4D8A-B711-6F4BAD2B4F46Q40603263-25DCF7DF-FE7C-4167-BDDC-300F379F460BQ40603270-43F9A356-5983-445C-84C6-C9D1B8F2224BQ40603276-5995EA2A-19A0-4445-9984-F84117EEFCA5Q40603288-8208ACFE-3485-4869-9702-7D0DF07493EFQ40603292-7AD15FAA-D9C5-4EE0-AAE7-41DC1C202282Q40603299-601BFB26-9C87-4B5E-A768-D5D76BD1E0B2Q40603306-F6230563-47D8-4A1D-B3DC-64D8C1C9AB7AQ40603313-5B8B4B6F-76D7-4270-82A0-1CF074BF2972Q40603318-E576C868-BD94-4FA9-B4B5-EAF072421CA5Q40624840-FC84495A-6658-4AB4-8422-0707421099D1
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
Advances in neuroimmunology
@ast
Advances in neuroimmunology
@en
Advances in neuroimmunology
@es
Advances in neuroimmunology
@it
Advances in neuroimmunology
@nl
type
label
Advances in neuroimmunology
@ast
Advances in neuroimmunology
@en
Advances in neuroimmunology
@es
Advances in neuroimmunology
@it
Advances in neuroimmunology
@nl
altLabel
Adv Neuroimmunol
@en
Adv. Neuroimmunol.
@en
prefLabel
Advances in neuroimmunology
@ast
Advances in neuroimmunology
@en
Advances in neuroimmunology
@es
Advances in neuroimmunology
@it
Advances in neuroimmunology
@nl
P3181
P1055
P1156
P123
P1476
Advances in neuroimmunology
@en